Venous thromboembolism is markedly higher in patients with COVID-19 in the intensive care unit, but routine screening is not recommended. Shruti Gadre, MD, discusses when to consider testing and how to manage care.
Severe COVID-19 is associated with a hypercoagulable state that often requires changes to usual inpatient anticoagulation strategies. We share our approach, including thromboprophylaxis protocols and a case vignette.
Study finds that not accounting for individual risk factors can lead to mistakes in prescribing anticoagulants, which can increase morbidity and mortality in cancer patients.